| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |